Vor Biopharma VOR EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Vor Biopharma’s reported figures.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's EBIT?
- Vor Biopharma (VOR) reported EBIT of -$35.16M in Q1 2026.
- How has Vor Biopharma's EBIT changed year-over-year?
- Vor Biopharma's EBIT decreased by 5.6% year-over-year, from -$33.29M to -$35.16M.
- What is the long-term trend for Vor Biopharma's EBIT?
- Over 4 years (2021 to 2025), Vor Biopharma's EBIT has grown at a 52.3% compound annual growth rate (CAGR), from -$69.02M to -$371.64M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.